Iradimed (IRMD) Accumulated Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Accumulated Expenses data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses fell 8.85% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 8.85% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 14.69% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $2.1 million, down from $3.2 million in the prior quarter.
• Over the last five years, Accumulated Expenses for IRMD reached as high as $4.1 million in Q3 2025 and fell as low as $1.6 million in Q1 2023.
• Historically, Accumulated Expenses has averaged $2.7 million across 5 years, with a median of $2.3 million in 2022.
• Across the five-year window, Accumulated Expenses soared 52.31% in 2022 and retreated 14.69% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $2.9 million in 2022, then dropped by 3.37% to $2.8 million in 2023, then surged by 35.92% to $3.8 million in 2024, then retreated by 14.69% to $3.2 million in 2025, then tumbled by 35.8% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $2.1 million in Q1 2026, $3.2 million in Q4 2025, and $4.1 million in Q3 2025.